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Abstract
Four medicinal plants Acacia nilotica, Bombax buonopozense, Terminalia avicennioides and Zanthoxylum zanthoxyloides
traditionally used for treatment of sleeping sickness in Nupeland were investigated for in vivo antitrypanosomal activity. Methanol
extracts of different parts of each plant (stem barks and fruits) were obtained and evaluated for their in vivo antitrypanosomal
activities against Trypanosoma brucei brucei. Phytochemical screening of the methanol extracts of each plant were performed by
standard procedures. Methanol extracts of A. nilotica (stem bark), B. buonopozense (stem bark), T. avicennioides (round fruit) and
Z. zanthoxyloides (stem bark) were effective on trypanosomes. The extracts of A. nilotica and B. buonopozense exhibited
antitrypanosomal effects at 200 and 300 mg/kg body weight respectively. Doses were able to clear the parasites from circulation
within 6 and 7 days of treatment respectively with prolonging survival period of up to 30 days. While the extracts of T.
avicennioides and Z. zanthoxyloides showed trypanostatic effects and could not clear the parasites completely. The methanol
extracts of these plants contain metabolites that are associated with antitrypanosomal effects; therefore, these medicinal plants may
be sources of new compounds that may be active against T. b. brucei. This study has also justified the claim that some medicinal
plants of Nupeland possess antitrypanosomal activity and could be useful in the management of trypanosomiasis.
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Introduction
Nigeria’s biodiversity is rich in medicinal plants. Over 25% of our common medicines contain at least some compounds
obtained from plants (Farnsworth, 1988). The World Health Organization reported that 70–90% of the worlds population relies
chiefly on traditional medicine (WHO, 2004) and a major part of the traditional therapies involve the use of plant extracts or their
active constituents. The local use of natural plants as primary health remedies is due to their pharmacological properties. Many
plant extracts owe their potency to the presence of metabolites. These metabolites are usually found in various parts of the plants
like roots, leaves, shoots and bark. Many plants have therefore become sources of important drugs and as such the pharmaceutical
industries have exploited traditional medicine as a source of bioactive agents that can be used in the preparation of synthetic
medicine (Kinghorn, 1994). Natural products play important roles in drug discovery and development process, particularly in the
field of infectious diseases, where 75% of these drugs are of natural origin (Newman et al., 2003).
Trypanosomiasis, a disease of major importance in human and animals has continued to threaten human health and
economical development (WHO, 1995; Kuzoe, 1993). T. b. gambiense and T. b. rhodesiense as the etiological agents of
trypanosomiasis affect millions of people in sub-Saharan Africa and are responsible for the death of about half a million patients
per year (Barrett, 1999).
Chemotherapy is the most widely used means of controlling the trypanosomiasis. The few registered trypanocides are often
associated with severe side effects (Guttering, 1985) and require lengthy parenteral administration, lack efficacy and are
unaffordable for most of the patients (Legros et al., 2002). There is urgent need to source for new, cheap and safe alternative
chemotherapy against trypanosomiasis from natural origin.
In African countries where sleeping sickness is endemic, plants have traditionally been used for generations and are still
widely used to treat this ailment with possible therapeutic activities, which have not been proved scientifically. However, Nupeland
located on the coastal basins of Rivers Niger and Kaduna in North Central Nigeria is greatly influenced by the savannah-forest
vegetations of the area. Naturally, this type of vegetation harbours tsetsefly which are the vector of trypanosomes, thus making the
area highly endemic to sleeping sickness. Nupeland inhabited predominantly by Nupe tribe are agrarian in nature and practice
farming with traditional medicine. Nupe tribe is traditionally noted for centuries of using medicinal plants in curing human
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trypanosomal infections among the indigenous people of Nupeland (Mann et al., 2003). Natural products derived from plants offer
novel possibilities to obtain new drugs that are active against trypanosomes (Hoet et al., 2004).
Some Nigerian medicinal plants have been evaluated for their in vitro trypanocidal activity (Adewunmi et al.,
2001; Atawodi et al., 2003; Maikai et al., 2008; Ogbunugafor et al., 2007; Owolabi et al., 1990; Shuaibu et al., 2008; Wurochekke
and Nok, 2004) and in vivo antitrypanosomal efficacies in mice (Abubakar et al., 2005 ; Asuzu and Chineme,1990 ; Asuzu and
Ugwuja 1989; Ibrahim et al., 2008 ; Mann et al., 2009 ; Ogbadoyi et al., 2007). The discovery of these potent antitrypanosomal
extracts from plant has increased the great potentials of plant species to provide lead compounds for the development of new
natural drugs for effective treatment of sleeping sickness. Therefore, the present study aimed to investigate the in vivo
antitrypanosomal activity of Nupeland medicinal plants against T. b. brucei.
Materials and Methods
Plant materials
The plant materials (Z. zanthoxyloides (stem bark) T. avicennioides (round fruit) A. nilotica (stem bark) B. buonopozense
(stem bark) with the following voucher Nos.: NIPRDH 68033, NIPRDH 5735, NIPRDH 02, NIPRDH 128 respectively were
collected from a forest near Emitete village along Bida-Doko Road in Lavun local Government area of Niger State, Nigeria as
described by the healers. They were botanically identified at the Herbarium Unit of the Department of Medicinal Plant Research
and Traditional Medicine, National Institute for Pharmaceutical Research and Development, Garki – Abuja, Nigeria where voucher
specimens were deposited.
Preparation of plant extract
The plant parts were air–dried to a constant weight. The dried parts were ground first into coarse form using a pestle and
mortar and then reduced to a powdery form using a mill.
Preparation of crude plant extracts
The powdery plant materials (250 g) were separately soaked in 500 ml of 70% methanol each for 24 hr with constant
stirring. The extracts were filtered through a clean muslin cloth (2 mm) and concentrated using a rotary evaporator. The
concentrated extracts were dried under a ceiling fan at room temperature. The residue was weighed and used in the preparation of
the stock extract for administration.
Phytochemical screening of extracts
Phytochemical screening of the plant extracts were carried out to assess the concentration of Alkaloids (Dragendorff’s,
Mayer’s, and Wagner’s reagents), Anthraquinones (Borntrager’s test), Balsams (Ferric chloride solution test), Carbohydrate
(Fehling’s solution test), Cardiac glycosides (Salkowski’s test and Keller-Kiliani’s test), Flavonoids (Lead acetate test, Ferric
chloride test, Shinoda’s test), Resins (Acetic anhydride test + conc. HS2O4), Saponins (Froth test and Legal test), Tannins (Ferric
chloride solution test, Bromine water test and Formaldehyde test), Terpenes (Liebermann–Burchard’s test) in each plant sample
using standard methods (Harborne, 1989; Sofowora, 1993; Trease and Evans, 1989).
Trypanosome stock
A stabilate of pleomorphic trypanosome bruce, strain (Trypanosoma brucei brucei) was obtained from the Nigerian Institute
for Trypanosomiasis Research Vom, near Jos, Nigeria and maintained in the Laboratory of Department of Biochemistry by serial
passage in mice.
Experimental animals
Mice used were purchased from the University of Ibadan and Ilorin and kept in well ventilated plastic cages. They were
exposed to 12 hr light and dark cycles and allowed free access to growers feed and water. The experiment was conducted in
compliance with international accepted principles for laboratory animal use. Animal care guidelines on animal use protocol review
(CCAC, 1997). The animals were allowed a 7-day period of acclimatization before they were divided into four groups of four
animals per cage.
Inoculation of donor mice
Blood was collected by cardiac puncture with an EDTA coated syringe from a heavily infected mouse and immediately
diluted with physiological saline. The dilute infected blood contains 1 or 2 parasite per field (microscopic field) 0.1ml of this blood
was inoculated into two clean healthy mice intraperitoneally to serve as the donor. Infection was monitored every morning by
microscopic examination of blood samples taken from the tail of the two infected mice.
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Infection of animals
Blood was collected by cardiac puncture with an EDTA coated syringe from the heavily infected mouse and immediately
diluted with physiological saline to serve as the inoculum. Healthy mice were infected intraperitoneally with 0.01ml of the
inoculums containing about 103 trypanosome cells. The extracts were administered every morning and parasitaemia was
monitored every two days by microscope examination.
Extract administration
In order to determine the effective dose, seven groups of three mice each were distributed into cages. Four groups (I-IV) of
mice were intraperitoneally administered extract at doses of 100, 200, 300 and 500 mg/kg body weight per day. Group V was
administered with Diminazene aceturate, Berenil (standard drug) at 3.5 mg/kg body weight per day. Group VI consist of the
negative control which were infected with the parasite but were not treated with the extract. Group VII which were made up of
Positive control were neither infected nor treated with the extract. Treatment was daily for 5 consecutive days. Parasitaemia was
monitored every two days under the microscope.
Therapeutic monitoring of extract
Development of parasitaemia in these rats was checked daily by wet blood film prepared from tail blood at x40
magnification. The number of parasite seen per field under the microscope was counted as described by Herbert and Lumsden
(1976).
Results
The plant extracts were percolated under laboratory conditions, and concentrated in vacuo with a rotary evaporator.
Saponins, tannins and terpenes have been identified in all plant parts tested in all the four species. Alkaloids were found in only B.
buonopozense. Flavonoids were also found in the extracts of A. nilotica (stem bark), T. avicennioides (round fruit) and Z.
zanthoxyloides (stem bark) (Table 1).
Table 1: Phytochemical analysis of six crude plant extracts
























































Key + = present, - = absent
Antitrypanosomal activity of crude plant extracts and their acute toxicity
The acute toxicity of the extracts were determined and the appropriate dosage used for the trypanocidal efficacy. Those
groups that were administered doses of 500mg/kg body weight served as controls to check death resulting from the acute toxicity.
For instance, the group administered with Z. zanthoxyloides at doses of 500mg/kg body weight died on the fifth day of treatment.
This shows that the extract was acutely toxic, because of the toxicity; the only dose that could suppress the activity of the parasite
was 100mg/kg body weight because they stayed six days after the death of the control. Those treated with 200mg/kg body weight
stayed four days after the death of the control as shown in table 2. The group treated with the standard drug, Diminazene aceturate
Mann et al., J Tradit Complement Altern Med. (2011) 8(1):15-21 18
(Berenil) survived. The drug was able to clear the parasite from circulation within three days of treatment. The effects of medicinal
plant extracts on parasite count in mice infected with T. b. brucei are as shown in Tables II-V.
Table 2: Effect of A. nilotica on parasite count in mice infected with T. b. brucei
Post treatment days Group I Group II Group III Group IV Group V Group VI Group VII
2 0 0 0 0 0 0 0
4 8 5 0 D D 0 5
6 100 0 D 0 100
8 50 0 0 150
10 50 0 D 200
12 40 0 D
14 20 0
Key:
D = Death of mice
Group I - Infected but treated with 100mg/kg of the extract; Group II – Infected but treated with 200mg/kg of the extract; Group III
– Infected but treated with 300mg/kg of the extract; Group IV – Infected but treated with 500mg/kg of the extract; Group V
– Not infected but treated with 500mg/kg of the extract; Group VI – Infected but treated with 3.5mg/kg of Berenil; Group
VII – Infected but not treated.
Table 3: Effect of B. buonopozense on parasite count in mice infected with T. b. brucei
Post treatment days Group I Group II Group III Group IV Group V Group VI Group VII
2 10 5 0 5 0 0 20
4 30 25 10 10 0 5 50
6 50 15 5 10 0 10 100
8 D 10 3 5 0 0 D
10 D 0 D 0 0
12 0 0 0
14 0 0 0
Key:
D = Death of mice
Group I - Infected but treated with 100mg/kg of the extract; Group II – Infected but treated with 200mg/kg of the extract; Group III
– Infected but treated with 300mg/kg of the extract; Group IV – Infected but treated with 500mg/kg of the extract; Group V
– Not infected but treated with 500mg/kg of the extract; Group VI – Infected but treated with 3.5mg/kg of Berenil; Group
VII – Infected but not treated.
Table 4: Effect of T. avicennioides on parasite count in mice infected with T. b. brucei
Post treatment days Group I Group II Group III Group IV Group V Group VI Group VII
2 0 0 0 0 0 0 0
4 0 0 10 25 0 0 10
6 10 50 60 60 0 5 150
8 50 D 100 90 0 0 D
10 100 100 90 0 0
12 D 150 D 0 0
14 D D 0
Key:
D = Death of mice
Group I - Infected but treated with 100mg/kg of the extract; Group II – Infected but treated with 200mg/kg of the extract; Group III
– Infected but treated with 300mg/kg of the extract; Group IV – Infected but treated with 500mg/kg of the extract; Group V
– Not infected but treated with 500mg/kg of the extract; Group VI – Infected but treated with 3.5mg/kg of Berenil; Group
VII – Infected but not treated.
Discussion
Investigation of antitrypanosomal activity of traditionally used plants has been a major area of contemporary research focus.
Natural products such as alkaloids, terpenes, quinones, and polyphenols found in these extracts have been shown to be potent
growth inhibition of T. cruzi (Wright and Pillipson, 1990). Triterpenoids and sterols from the plants are reported to possess
antitrypanosomal activity (Hoet et al., 2007). The antitrypanosomal activities of alkaloids like actinodaphine, dicentine, cassythine
isolated from Cassytha filiformis (Hoet et al., 2004a) are also found in B. buonopozense and several other alkaloids (Merschjohann
et al., 2001) displayed significant in vitro antitrypanosomal activity. The DNA intercalation in combination with portion
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biosynthesis inhibition is reported to be the mechanism of action responsible for the observed anti-trypanosomal effect of the active
alkaloids (Merschjohann et al., 2001). The trypanocidal activity of several flavonoids such as quercetagetin (Hoet et al., 2004b);
hispidulin and santin (Sülsen et al., 2007) has been previously reported. An azaanthraquinone early reported in A. nilotica was
associated with the observed antitrypanosomal effects (Nok, 2002).
Table 5: Effect of Z. zanthoxyloides on parasite count in mice infected with T. b. brucei
Post treatment days Group I Group II Group III Group IV Group V Group VI Group VII
2 0 0 0 0 0 0 0
4 0 0 0 0 0 0 80
6 0 0 0 D D 8 90
8 80 80 65 0 100
10 100 100 100 0 D
12 100 110 100 0
14 120 D D 0
Key:
D = Death of mice
Group I - Infected but treated with 100mg/kg of the extract; Group II – Infected but treated with 200mg/kg of the extract; Group III
– Infected but treated with 300mg/kg of the extract; Group IV – Infected but treated with 500mg/kg of the extract; Group V
– Not infected but treated with 500mg/kg of the extract; Group VI – Infected but treated with 3.5mg/kg of Berenil; Group
VII – Infected but not treated.
Antitrypanosomal activity of crude plant extracts tested in vivo
The crude extract of the stem bark of Z. zanthoxyloides shows no trypanocidal activity. However, it was found to be
trypanostatic since parasite were undetected between day one of infection and day five of treatment. The present result showed that
100mg/kg of the doses administered is trypanostatic because the parasitaemia was kept relatively low when compared to the
untreated. The group infected but not treated died between the 7th day and 8th day of infection while those infected and treated died
days after.
In our present studies, we focused on in vivo screening of Z. zanthoxyloides (stem bark) T. avicennioides (round fruit), A.
nilotica (stem bark) and B. buonopozense (stem bark) which are the plant parts prominently used in Nupe Ethnomedicine (Mann et
al., 2003). Therefore, the antitrypanosomal activity of four crude methanol extracts of medicinal plants from Nupeland was
determined in vivo using T. b. brucei as shown in Tables II-IV. The crude extract of the stem bark of Z. zanthoxyloides had no
trypanocidal effect, even though its root bark extract was reported to be active (Igweh and Onabanjo, 1989). The failure of the
crude extract of the stem bark of Z. zanthoxyloides to show any trypanocidal action depicts that the anti-trypanosomes are lacking
in the stem bark as opposed to the claims by the healers which according to the existing literature is used in Nupe ethnomedicine in
the management of sleeping sickness in Nupeland (Mann et al., 2003)However, we have also observed that the crude extract of the
stem bark of Z. zanthoxyloides was found to exhibit trypanostatic activity. Similar to the early reports of the trypanostatic effect of
ethanolic extract of the stem bark of F. albida and it is also effective in the management of anaemia induced by T. b. brucei in rats
(Tijani et al., 2009). Trypanostatic effect is said to suppress the activity of the parasite there by sustaining the life of the mice when
compared to the control group. It is worthy to mention that some plants have already been investigated for their antitrypanosomal
activity in other studies. For instance; water, methanol and dichloromethane extracts of the leaves of T. avicennioides tested, but
only methanolic extracts were active on T. b. brucei (Bizimana et al., 2006). Stem bark extracts of the same plant species has
shown in vitro effect against T. b. brucei (Shuaibu et al., 2008).
In our present studies, the round fruit extract of T. avicennioides tested for its in vivo antitrypanosomal activity gave a
result that are efficaciously comparable to those of previous investigators who showed that extracts of T. avicennioides were active
in vitro on T. b. brucei (Bizimana et al., 2006; Shuaibu et al., 2008). T. avicennioides (round fruit) and Z. zanthoxyloides (stem
bark) were effective on trypanosomes trypanostatically only.
The most interesting results are those of A. nilotica and B. buonopozense extracts which showed the antitrypanosomal
effects at 200 and 300 mg/kg body weight respectively representing the first time in vivo activity of B. buonopozense and Z.
zanthoxyloides on trypanosome, T. b. brucei is being reported. Doses were able to clear the parasites from circulation within 6 and
7 days of treatment respectively with prolonging survival period of up to 30 days. While the extracts of T. avicennioides and Z.
zanthoxyloides showed trypanostatic effects and could not clear the parasites completely.
From the phytochemical studies, the type of compounds which could be responsible for the antitrypanosomal activities
are associated with the metabolites and the results obtained showed that the crude extract of Z. zanthoxyloides contain some
metabolites that suppresses the activity of the trypanosomes rather than killing the parasites completely.
This study has provided evidence that T. avicennioides and Z. zanthoxyloides extracts exhibits trypanostatic effect which
is often associated with reduction in anemia and promote weight gain in experimental African trypanosomiasis (Ogbadoyi et al.,
1999). Anaemia is the most outstanding clinical and laboratory feature of African trypanosomiasis (Bizimana et al., 2006) and also
the primary cause of death (Mamo and Holmes, 1975). The stem bark of Z. zanthoxyloides is used in treating sickle cell anaemia
and analgesic (Mann et al., 2003). Trypanostatic effect of the plant extracts were explained with corresponding increase in PCV
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which prolong the lifespan of treated animals by reducing the parasite load or neutralizing the toxic metabolites produced by
trypanosomes (Abubakar et al., 2005). Based on these results and the fact that plant part extracts are traditionally used in the
treatment of African Trypanosomiasis, we analyzed in greater detail the antitrypanosomal activity of the stem bark methanol
extracts of the four plants. Nevertheless, the activity values for the active extracts were high compared to the values obtained for
commonly used trypanocidal drugs diminazene aceturate. However, since the crude extracts have a very complex composition,
purification might lead to pure compounds with highly increased activity. Such differences between our results and those of other
authors may be due to the known variation in the chemical composition of plants according to the geographical area and the time or
season of collection (Shuaibu et al., 2008).
In our in vivo studies, with mice infected with T. b. brucei; the methanol extracts of round fruit of T. avicennioides and stem
barks of Z. zanthoxyloides and A. nilotica and B. buonopozense were investigated, but only A. nilotica and B. buonopozense were
found to be significantly active. The antitrypanosomal activity of four crude methanol extracts of medicinal plants from Nupeland
determined by in vivo using T. b. brucei, only A. nilotica and B. buonopozense were the most promising ones. This is the first report
of in vivo antitrypanosomal activity of these two plants. The results of the present study confirmed that the use of medicinal plants
in folk medicine contributes significantly to primary health care, and that natural products are potential sources of new drugs for the
treatment of important tropical diseases caused by trypanosomes. The high activity values obtained for these plants render them
candidates for the isolation of anti-trypanosomal compounds which could be developed into new lead structures for drug
development. Therefore, the trypanocidal effects of extracts will require further experimentation after fractionation and
characterization using chromatographic and spectroscopic techniques, a work that is currently in progress.
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